RU93044224A - PHARMACEUTICAL COMPOSITION POSSESSING AGONISTIC ACTIVITY FOR 5 NT1 - SIMILAR RECEPTORS - Google Patents
PHARMACEUTICAL COMPOSITION POSSESSING AGONISTIC ACTIVITY FOR 5 NT1 - SIMILAR RECEPTORSInfo
- Publication number
- RU93044224A RU93044224A RU93044224/14A RU93044224A RU93044224A RU 93044224 A RU93044224 A RU 93044224A RU 93044224/14 A RU93044224/14 A RU 93044224/14A RU 93044224 A RU93044224 A RU 93044224A RU 93044224 A RU93044224 A RU 93044224A
- Authority
- RU
- Russia
- Prior art keywords
- agonistic activity
- pharmaceutical composition
- composition possessing
- similar receptors
- receptors
- Prior art date
Links
- 230000001270 agonistic Effects 0.000 title claims 2
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- 206010019233 Headache Diseases 0.000 claims 1
- 230000002378 acidificating Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Claims (1)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9027827.6 | 1990-12-21 | ||
GB909027827A GB9027827D0 (en) | 1990-12-21 | 1990-12-21 | Pharmaceutical compositions |
PCT/EP1991/002425 WO1992011003A1 (en) | 1990-12-21 | 1991-12-17 | Pharmaceutical compositions |
SG169594A SG169594G (en) | 1990-12-21 | 1994-12-01 | Effervescent pharmaceutical compositions containing a 5HT-receptor agonist |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93044224A true RU93044224A (en) | 1997-01-27 |
RU2110992C1 RU2110992C1 (en) | 1998-05-20 |
Family
ID=26298162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93044224A RU2110992C1 (en) | 1990-12-21 | 1991-12-17 | Carbonated pharmaceutical composition for oral administration |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0563094B1 (en) |
JP (1) | JP3425949B2 (en) |
KR (1) | KR100188172B1 (en) |
AT (1) | ATE127688T1 (en) |
AU (1) | AU654313B2 (en) |
BE (1) | BE1004182A3 (en) |
CA (1) | CA2099585C (en) |
CH (1) | CH684161A5 (en) |
CZ (1) | CZ281042B6 (en) |
DE (1) | DE69113062T2 (en) |
DK (1) | DK0563094T3 (en) |
ES (1) | ES2078727T3 (en) |
FR (1) | FR2670674B1 (en) |
GB (2) | GB9027827D0 (en) |
GR (1) | GR3017701T3 (en) |
HK (1) | HK18795A (en) |
IE (1) | IE914482A1 (en) |
IL (1) | IL100452A (en) |
IT (1) | IT1252599B (en) |
MX (1) | MX9102733A (en) |
NZ (1) | NZ241098A (en) |
RU (1) | RU2110992C1 (en) |
SG (1) | SG169594G (en) |
WO (1) | WO1992011003A1 (en) |
ZA (1) | ZA9110052B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2714064B1 (en) * | 1993-12-16 | 1996-03-08 | Edmond Creppy | Aspartame for its application as a therapeutically active substance. |
GB0129117D0 (en) * | 2001-12-05 | 2002-01-23 | Glaxo Group Ltd | Pharmaceutical composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
IE59106B1 (en) * | 1985-05-31 | 1994-01-12 | Warner Lambert Co | A therapeutic effervescent composition and a method of preparing the same |
FR2593065B1 (en) * | 1986-01-22 | 1988-09-09 | Smith Kline French Lab | EFFERVESCENT COUPLES, EFFERVESCENT COMPOSITIONS OF HISTAMINE H2 ANTAGONISTS CONTAINING THEM AND THEIR PREPARATION. |
GB8909793D0 (en) * | 1989-04-28 | 1989-06-14 | Beecham Group Plc | Pharmaceutical formulation |
-
1990
- 1990-12-21 GB GB909027827A patent/GB9027827D0/en active Pending
-
1991
- 1991-12-17 CA CA002099585A patent/CA2099585C/en not_active Expired - Fee Related
- 1991-12-17 KR KR1019930701894A patent/KR100188172B1/en not_active IP Right Cessation
- 1991-12-17 JP JP50165892A patent/JP3425949B2/en not_active Expired - Fee Related
- 1991-12-17 RU RU93044224A patent/RU2110992C1/en not_active IP Right Cessation
- 1991-12-17 DE DE69113062T patent/DE69113062T2/en not_active Expired - Fee Related
- 1991-12-17 AU AU90665/91A patent/AU654313B2/en not_active Ceased
- 1991-12-17 DK DK92900531.2T patent/DK0563094T3/en active
- 1991-12-17 CZ CS931225A patent/CZ281042B6/en not_active IP Right Cessation
- 1991-12-17 EP EP92900531A patent/EP0563094B1/en not_active Expired - Lifetime
- 1991-12-17 ES ES92900531T patent/ES2078727T3/en not_active Expired - Lifetime
- 1991-12-17 WO PCT/EP1991/002425 patent/WO1992011003A1/en active IP Right Grant
- 1991-12-17 AT AT92900531T patent/ATE127688T1/en not_active IP Right Cessation
- 1991-12-19 GB GB9126957A patent/GB2250917B/en not_active Expired - Fee Related
- 1991-12-20 BE BE9101174A patent/BE1004182A3/en not_active IP Right Cessation
- 1991-12-20 IL IL10045291A patent/IL100452A/en not_active IP Right Cessation
- 1991-12-20 FR FR9115879A patent/FR2670674B1/en not_active Expired - Fee Related
- 1991-12-20 ZA ZA9110052A patent/ZA9110052B/en unknown
- 1991-12-20 IE IE448291A patent/IE914482A1/en not_active IP Right Cessation
- 1991-12-20 IT ITRM910963A patent/IT1252599B/en active IP Right Grant
- 1991-12-20 MX MX9102733A patent/MX9102733A/en not_active IP Right Cessation
- 1991-12-20 NZ NZ241098A patent/NZ241098A/en unknown
- 1991-12-20 CH CH3791/91A patent/CH684161A5/en not_active IP Right Cessation
-
1994
- 1994-12-01 SG SG169594A patent/SG169594G/en unknown
-
1995
- 1995-02-09 HK HK18795A patent/HK18795A/en not_active IP Right Cessation
- 1995-10-11 GR GR950402810T patent/GR3017701T3/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2293823A1 (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
DE122010000050I1 (en) | SUBLINGUAL OR BUKKALES MEDICINES | |
PL315636A1 (en) | Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives | |
CA2124677A1 (en) | Immunopotentiatory agents and physiologically acceptable salts thereof | |
IL149496A (en) | Pharmaceutical combinations and their use in treating gastrointestinal disorders | |
CA2129995A1 (en) | Piperidinyl thiacyclic derivatives | |
RU93004793A (en) | HINAZOLIN DERIVATIVES, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION ON THEIR BASIS | |
IL97892A0 (en) | 2,9-disubstituted-4h-pyrido(1,2-a)pyrimidin-4-ones,their preparation and pharmaceutical compositions containing them | |
CA2202397A1 (en) | Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders | |
GR3019274T3 (en) | Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use | |
CA2127472A1 (en) | New adenosine derivatives, preparation methods and pharmaceutical compositions containing them | |
RU93004535A (en) | COMPOUNDS, METHOD OF OBTAINING AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS | |
IT9019112A1 (en) | PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR THE ORAL ADMINISTRATION OF CALCITONIN | |
YU242789A (en) | New compound, 4-fluoro-2-//(4-metoxy-2-pyridin-yl)methylsulphinyl/-1h-benzimidazole and process for obtaining | |
RU93044224A (en) | PHARMACEUTICAL COMPOSITION POSSESSING AGONISTIC ACTIVITY FOR 5 NT1 - SIMILAR RECEPTORS | |
IT9019793A0 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE | |
SE8402199L (en) | PHARMACEUTICAL PREPARATION CONTAINING CO-DERGOCRIN AND A CALCIUM ANTAGONIST | |
SE9202218D0 (en) | PHARMACOLOGICALLY ACTIVE ALFA (TERTIARY AMINOMETHYL) -BENZENEMETHANOL DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THEM, THERAPEUTICAL USE THEREOF AND PROCESSES FOR THEIR PREPARATION | |
CA2423288A1 (en) | New pharmaceutical compositions containing epinastine and pseudoephedrine | |
ITRM950589A0 (en) | USE OF NATURAL CYTOKINE MUTEINS AS IMMUNOGENS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS TO TREAT OR PREVENT DISEASES CAUSED BY THE OVERPRODUCTION OF THESE NATURAL CYTOKINES, AND PHARMACEUTICAL COMPOSITIONS SO OBTAINABLE | |
IT9021021A0 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF HIRUDIN | |
CA2099585A1 (en) | Pharmaceutical compositions | |
ITMI911445A0 (en) | USE OF PHOSPHOLIPIDE DERIVATIVES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS HAVING IMMUNOSUPPRESSIVE ACTIVITY | |
HU9503351D0 (en) | Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis | |
GB9211277D0 (en) | Pharmaceutical compositions |